Without these I think we just have another relief rally.
We'll sell a portion of FCX to have cash to buy some beaten-down names.
The pharmaceutical division was the standout performer.
The pullback offers an opportunity to build up our position in AbbVie.
We're sowing the seeds of our own demise.
Catch up on Jim Cramer's thinking over the last week about the reversals in the oil and travel markets, and the results of Alcoa's tough action.
We moved positions around and we added to and subtracted from the portfolio as markets were roiled this week.
We expect to see further upside throughout the rest of the year.
We will buy shares in Macy's and AbbVie.